¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"morphine like drug"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® morphine ÇÑ±Û ¸ð¸£ÇÉ
¼³¸í   
  ¾ÆÆí°èÅëÀÇ ¸¶¾à. À̸¥¹Ù ¾ç±Íºñ¿¡¼­ ÃßÃâÇÏ¿© ¸¸µç´Ù.
  
  ÀÌ·¸°Ô ¹Ù·Î ¾ÆÆí¿¡¼­ ÃßÃâÇϴ ¾àÀ» opiate¶ó°í ÇÏÁö¸¸, ±×·¸Áö ¾Ê°í ¾ÆÆíÀ» È­ÇÐÀûÀ¸·Î º¯È­½ÃÄÑ ÀÛ¿ë½Ã°£À̳ª, ÀÛ¿ëÁ¤µµ¸¦ ¹Ù²Û ¾àÀº opioids¶ó°í ÇÑ´Ù. ´ë°³ ¸¶¾à·ù°èÅëÀÇ ¾àÀº ÀÇÁ¸Áõ»ó(dependency)°ú, Áßµ¶Áõ»ó(intoxication), ±×¸®°í ±× ¾àÀ» ²÷À» ¶§ »ý±â´Â ±Ý´ÜÁõ»ó(withdrawal symptom) µîÀ» À¯¹ßÇϴµ¥, ½ÇÁ¦·Î´Â ¸ðµç ¾àÀÌ ÀÌ·± Áõ»óÀ» ³ªÅ¸³»Áö´Â ¾Ê´Â´Ù. ¶ÇÇÑ ¾àÀÇ Á¾·ùµµ ´Ù¾çÇϸç, ±× ÀÛ¿ëµµ °¢±â ´Ù¸£´Ù. ±× Á¾·ù¸¦ º¸¸é ´ÙÀ½°ú °°´Ù.
  
  ¾ÆÆí°èÅë: À̸¥¹Ù ¾ç±Íºñ¿¡¼­ ÃßÃâµÇ´Â ¾àµé·Î ÈçÈ÷ ¸¶¾àÇϸé, ÀÌ ¾àÀ» ÁöĪÇÑ´Ù. Á¾·ù·Î Heroin, Morphine, Meperidine(Demerol), Codeine µîÀÌ ÀÖÀ¸¸ç Áßµ¶Áõ»ó(Áö³ªÄ£ ¾àÀÇ º¹¿ëÀ¸·Î »ý±â´Â Áõ»ó)À¸·Î´Â µ¿°ø¼öÃà, ´ÙÇà°¨(euphoria), ¶ÇÇѠȣÈí¿îµ¿¾ïÁ¦ µîµµ ³ªÅ¸³ª »ý¸í¿¡ ÁöÀåÀ» ÁÙ ¼öµµ ÀÖ´Ù. ±Ý´ÜÁõ»ó(¾àÀ» ²÷À» ¶§ »ý±â´Â Áõ»ó)À¸·Î´Â º¹Åë, ´«¹°, Ä๰, µ¿°øÈ®´ë, ±ÙÀ°Åë, °üÀýÅ렵¡Àå °Ý·ÄÇÑ Áõ»óÀÌ ³ªÅ¸³ª ´ë°³ °ßµð±â ¾î·Á¿î »óŰ¡ µÈ´Ù.
¿µ¹® antihypertensive drug ÇÑ±Û °íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
¼³¸í   
  °íÇ÷¾ÐÀÇ Ä¡·á¿¡ »ç¿ëÇϸ砳ôÀº Ç÷¾ÐÀ» ³·Ãߴ ¾à¹°À» ¸»ÇÑ´Ù. °íÇ÷¾Ð¾à¿¡´Â Ç÷°üÆòȰ±Ù¿¡ Á÷Á¢ ÀÛ¿ëÇÏ¿© À̿ϽÃ۴ Ç÷°üÈ®ÀåÁ¦(È÷µå¶ó¶óÁø), ±³°¨½Å°æÀǠȰµ¿À» ¾îµð¼±°¡ Â÷´ÜÇϴ ¾à¹°(·¹¼¼¸£ÇÉ, ¸ÞÆ¿µµÆÄ, ÇÁ·ÎÇÁ¶ó³ë·Ñ), ÀÌ´¢Á¦(ÇÁ·Î¼¼¹Ìµå, ¿¡Å¸Å©¸°»ê)ÀÌ »ç¿ëµÈ´Ù.
¿µ¹® antimalarial drug ÇÑ±Û ¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
¼³¸í   
  ¸»¶ó¸®¾Æ Ä¡·á¿¡ ¾²´Â ¾à. Å°´Ï³×, Å¬·Î·ÎÄý, ÇÁ¸®¸¶Äý µûÀ§°¡ ÀÖ´Ù. ¸»¶ó¸®¾Æ ¿øÃæÀÇ ¹ßÀ°Áֱ⿡ ´ëÀÀÇØ¼­ ¾à¹°ÀÌ ÀÖÀ¸³ª ´ëºÎºÐÀº º´¿ë¿ä¹ý¿¡ µû¶ó¼­ ¸»¶ó¸®¾Æ Ä¡·á¸¦ ÇÑ´Ù. ¸ð±â¿¡ ÀÇÇÑ Æ÷ÀÚü°¨¿°¿¡ ´ëÇÑ Çׯ÷ÀÚü ¾àÀº µ¶¼º µîÀÇ ¹®Á¦°¡ À־ ¾ÆÁ÷ ¾ø´Ù. ÀûÇ÷±¸³»¿¡¼­ÀǠȯ»óü, ¹ø½Äü¿¡¸¸ ÀÛ¿ëÇϴ °Í(Ç×¹ø½Äü ¾àÀº Å¬·Î·ÎÄý, ÇǸ®¸ÞŸ¹Î, Å¬·Î·Î±¸¾Æ³ªÀ̵å, Å°´Ï³×)Àº ÀûÇ÷±¸ ¿ÜÀÇ ¹ßÀ°Àº ¾ïÁ¦ÇÏÁö ¾ÊÀ¸¹Ç·Î °¨¿°À» ¿ÏÀüÈ÷ ÀúÁöµÇÁö ¾Ê´Â´Ù. ÀûÇ÷±¸³»¿ÜÀÇ ¿øÃæ¿¡ ÀÛ¿ëÇØ ¿ÏÀüÈ÷ °¨¿°À» ¾ïÁ¦Çϴ °Í(ÆÄ¸¶Å², ÆæÅ¸Å², ÇÁ¸®¸¶Å²), Ç÷ÁßÀÇ »ý½Äü¸¦ Á×À̴ °Í(´ëºÎºÐÀÇ Ç׸»¶ó¸®¾ÆÁ¦)Àº ¸ð±â¿¡ ÀÇÇѠŸÀÎÀ¸·ÎÀÇ Àü¿°¿øÀº ²÷±â´Âµ¥ È¯ÀÚÀÚ½ÅÀÇ Áõ»óÀº º¯È­ÇÏÁö ¾Ê´Â´Ù.
¿µ¹® drug ÇÑ±Û ¾à, ¾à¹°, ¾àÁ¦
¼³¸í   
  1. º´, ±âŸ º´Àû »óÅÂÀÇ Áø´Ü, Ä¡·á, ¿¹¹æÀ̳ª °íÅëÀÇ °æ°¨, ¶Ç´Â »ý¸®Àû, º´¸®Àû »óŸ¦ È£Àü½Ã۴ °ÍÀ» ¸ñÀûÀ¸·Î »ç¶÷ ¶Ç´Â µ¿¹°¿¡ Åõ¿©µÇ´Â È­ÇÕ¹°. ¾à¸®Çп¡¼­´Â Ä¡·á¾à¸¸ÀÌ ¾Æ´Ï¶ó, »ýü¿¡ ÁÖ¾îÁ³À» ¶§ ¾î¶°ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»´Â È­Çй°Áú ¸ðµÎ¸¦ ¾à¹°À̶ó°í ÇÑ´Ù. ÀÛ¿ëÀÌ °­ÇÏ°í ¾ÈÀü¼ºÀÌ ³·Àº ¼ø¼­·Î µ¶¾à-±Ø¾à-º¸Åë¾àÀ¸·Î ±¸ºÐÇϰí ÀÖ´Ù. ¾à¹°Ä¡·á¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀڷμ­, »ýüÂÊ ÀÎÀڷδ °³Ã¼Â÷, ¿¬·É, Ã¼Áß µîÀÌ ÀÖ°í, ¾à¹°ÂÊ ÀÎÀڷμ­´Â Åõ¿©¹æ¹ý, Åõ¿©·®, º´¿ëµÇ°í Àִ ´Ù¸¥ ¾à¹° µîÀÌ ÀÖ´Ù. 2. ¾àÀÇ Àç·á°¡ µÇ´Â ¹°Áú. 3. ¿©·¯ °¡Áö ¾àÀ縦 ¼¯¾î Á¶Á¦ÇÑ ¾à.
¿µ¹® drug resistance ÇÑ±Û ¾à¹°³»¼º
¼³¸í   
  1. È­Çпä¹ýÁ¦³ª Ç×»ý¹°ÁúÀÇ ¾î¶² ÀÏÁ¤ ³óµµ·Î ¼¼±ÕÀ» Á×À̰ųª Áõ½ÄÀúÇØ¸¦ ¹Þ´Â °ÍÀ» ÀÌ È­Çпä¹ýÁ¦³ª Ç×»ý¹°Áú¿¡ °¨¼ö¼ºÀÌ ÀÖ´Ù°í Çϴµ¥, ÀÌ °¨¼ö¼ºÀÌ ¾ø°Ô µÈ »ýŸ¦ ÀúÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. µû¶ó¼­ º¯À̹̻ý¹°ÀÇ ¾àÁ¦¿¡ ´ëÇÑ ÀÚÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. 2. ÀǾàǰÀ» °è¼Ó º¹¿ëÇϸé Á¡Â÷ Áõ·®ÇÏÁö ¾ÊÀ¸¸é È¿·ÂÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¼ºÁú. ÀÌ·¯ÇÑ ¶§¸¦ ¾àÁ¦³»¼ºÀÌ »ý°å´Ù°í ÇÑ´Ù. ¸ðµç ¹Ì»ý¹°Àº °¨¼ö¼ºÀ» °¡Áö´Â ¾à¹°¿¡ ÀÇÇÏ¿© »ç¸êµÇÁö¸¸, ¼Ò¼öÀÇ °ÍÀº »ì¾Æ³²¾Æ ±×°ÍÀÌ ÁøÈ­µÊÀ¸·Î½á »ç¸êÇÏÁö ¾Ê´Â ¼ö°¡ ÀÖ´Ù. ¶Ç, ÃÖÃÊ¿¡´Â °¨¼ö¼ºÀ» °¡Áö°í ÀÖ´ø ±ÕÀÌ Â÷Â÷ ³»¼º±ÕÀ¸·Î µÇ±âµµ ÇÑ´Ù. ¸¹Àº º´¿ø±ÕÀº °¨¼ö¼ºÀÌ Àִ ÀǾàǰ¿¡ ´ëÇÏ¿© ³»¼ºÀÌ »ý±ä´Ù. °¡Àå °íµµÀÇ ³»¼º±ÕÀÌ »ý±â±â ½¬¿î °ÍÀº ½ºÆ®·¾Å丶À̽ÅÀε¥ °áÇÙ±Õ°ú ±×¶÷À½¼º±Õ¿¡ ´ëÇÏ¿© ½±°Ô ³»¼ºÀÌ »ý±ä´Ù. Æä´Ï½Ç¸°À̳ª Åׯ®¶ó½ÃŬ¸°(¾ÆÅ©·Î¸¶À̽Å) µîÀÇ Ç×»ý¹°Áúµµ ³»¼ºÀÌ »ý±â±â ½¬¿ì¹Ç·Î, »ç¿ëÇÒ ¶§´Â ÀûÀÀÀ» Àß È®ÀÎÇÏ¿© Çʿ䷮À» Á¤ÇÏ°í ¿¬¿ëÀ» ÇÇÇÑ´Ù. °°Àº È¿°ú°¡ Àִ ´Ù¸¥ Á¾·ùÀÇ ¾àÁ¦¸¦ ¼Ò·®¾¿ 2, 3Á¾ º´¿ëÇϸ頳»¼ºÀÇ ¹ß»ýÀÌ Å©°Ô ¾ïÁ¦µÈ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. °áÇÙ¾àÀ¸·Î¼­ ½ºÆ®·¾Å丶À̽Űú ÆÄ½º, ¶Ç´Â À̼ҴϾÆÁöµå¸¦ º´¿ëÇϴ °Í µîÀÌ ±× ¿¹ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine
    ¸ð¸£ÇÉ
  • glucagon-like insulinotropic peptide
    ±Û·çÄ«°ïÀ¯»çÀν¶¸°ÀÚ±ØÆéÆ¼µå
  • glucagon-like peptide
    ±Û·çÄ«°ïÀ¯»çÆéƼµå
  • insulin-like activity
    Àν¶¸°À¯»çȰ¼ºµµ
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • lichen planus-like keratosis
    ÆíÆòż±À¯»ç°¢È­Áõ
  • map like skull
    Áöµµ¸Ó¸®»À, Áöµµ¸ð¾çµÎ°³°ñ
  • pleuropneumonia-like organism
    °¡½¿¸·Æó·Å¸ð¾ç±Õ, À¯È丷Æó·Å±Õ
  • reflex like reaction
    ¹Ý»ç¸ð¾ç¹ÝÀÀ
  • rosacea-like tuberculid
    Àå¹ÌÁõ¸ð¾ç°áÇÙ¹ßÁø
  • subcutaneous panniculitis-like T-cell lymphoma
    ÇÇÇÏÁö¹æÃþ¿°À¯»çT¼¼Æ÷¸²ÇÁÁ¾
  • antiallergic drug
    ¾Ë·¹¸£±â¾à, Ç׾˷¹¸£±âÁ¦
  • antiamebic drug
    ¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
  • antianxiety drug
    Ç׺ҾÈÁ¦, ºÒ¾ÈÄ¡·áÁ¦
  • antiarrhythmic drug
    ºÎÁ¤¸Æ¾à, Ç׺ÎÁ¤¸ÆÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine
    ¸ð¸£ÇÉ
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • antiamebic drug
    ¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
  • antiarrhythmic drug
    ºÎÁ¤¸Æ¾à, Ç׺ÎÁ¤¸ÆÁ¦
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
  • antiemetic drug
    ±¸Åä¾à, Ç×±¸ÅäÁ¦
  • antihistaminic drug
    Ç×È÷½ºÅ¸¹ÎÁ¦
  • antihypertensive drug
    °íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
  • antimalarial drug
    ¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
  • antiplatelet drug
    Ç×Ç÷¼ÒÆÇÁ¦
  • antiseizure drug
    °æ·Ã¾à, Ç×°æ·ÃÁ¦
  • antiseptic drug
    Ç×±Õ¾à
  • antituberculosis drug
    °áÇÙ¾à, Ç×°áÇÙÁ¦
  • antiviral drug
    ¹ÙÀÌ·¯½º¾à, Ç×¹ÙÀÌ·¯½ºÁ¦
  • nonsteroidal antiinflammatory drug
    ºñ½ºÅ×·ÎÀ̵å¼Ò¿°Á¦, ºñ½ºÅ×·ÎÀ̵åÇ׿°ÁõÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine euphoria
    ¸ð¸£ÇÉ´ÙÇà°¨, ¸ð¸£ÇÉÄè°¨
  • morphine acetate
    ÃÊ»ê¸ð¸£ÇÉ
  • organic schizophrenia-like disorder
    ±âÁúÁ¤½ÅºÐ¿­º´À¯»çÀå¾Ö
  • rosacea-like eruption
    µþ±âÄÚ¹ßÁø, Àå¹Ì¿©µå¸§¹ßÁø
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • lichen planus-like keratosis
    ÆíÆòż±¸ð¾ç°¢È­Áõ
  • map like skull
    Áöµµ¸Ó¸®»À, ÁöµµµÎ°³
  • pleuropneumonia-like organism
    À¯È丷Æó·Å±Õ
  • reflex like reaction
    ¹Ý»ç¸ð¾ç¹ÝÀÀ
  • rosacea-like tuberculid
    µþ±âÄÚ°áÇÙ¹ßÁø, Àå¹Ì¿©µå¸§°áÇÙ¹ßÁø
  • adrenergic drug
    ¾Æµå·¹³¯¸°ÀÛ¿ë¾à
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • antiallergic drug
    ¾Ë·¹¸£±â¾à, Ç׾˷¹¸£±âÁ¦
  • antiamebic drug
    ¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
  • antianxiety drug
    ºÒ¾È¾à, Ç׺ҾÈÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • OTC drug : over-the-counter drug
    ÀϹݸžà.
  • IGF-I(insulin-like growth factor-I)
    Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • Lewandowskys rosacea-like eruption
    ·¹¹Ýµµºê½ºÅ° ÁÖ»ç¾ç ¹ßÁø
  • Norwalk-like agent
    ³ë¸£¿ÍÅ©¾ç ü
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
  • anterior pituitary-like hormone =APLH
    ÇϼöüÀü¿±¾çÈ£¸£¸ó.
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • fungus, yeast-like
    È¿¸ðÇüÁø±Õ, È¿¸ð¾çÁø±Õ
  • plate like atelectasis
    ÆòÆÇ¾ç ¹«±âÆó, ÆÇ¾ç ¹«±âÆó
  • pleuropneumonia-like organism
    Æó´Á¸·¿°À¯»ç º´¿øÃ¼, PPLO, ¹ÌÄÚÇö󽺸¶
  • pleuropneumonia-like organisms(p.p.l.o)
    ¿ìÈ丷Æó·Å±Õ(éÚýØØ¯øËæúж)
  • ADR : adverse drug reaction
    ¾à¹°À¯ÇØÀÛ¿ë(å·ÚªêóúªíÂéÄ).
  • IND : investigational new drug
    ½ÃÇè¿ë½Å¾à.
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£Ç¥Çö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine like drug
    ¸ð¸£ÇÉÀ¯»ç¾à¹°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine
    ¸ð¸£ÇÉ
  • morphine acetate
    ÃÊ»ê(õ³ß«)¸ð¸£ÇÉ.
  • morphine euphoria
    ¸ð¸£ÇÉ´ÙÇà°¨(¡­Òýú¹Êï), ¸ð¸£ÇÉÄè°¨.
  • morphine meconate
    ¸ÞÄÜ»ê¸ð¸£ÇÉ.
  • morphine test
    ¸ð¸£ÇɽÃÇè(¡­ãËúÐ).
  • drug dependence ; drug dependency
    ¾à¹°ÀÇÁ¸(¼º).
  • anterior pituitary-like hormone =APLH
    ÇϼöüÀü¿±¾çÈ£¸£¸ó.
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • bud like
    »õ½Ï ¸ð¾ç
  • bud-like
    Á¸ÀÕ¸ï¸ï{Àº.
  • cell like colloidal drop
    ¼¼Æ÷¾çÄÝ·ÎÀ̵å¾×Àû.
  • comet like echo
    Çý¼º¸ð¾ç ¿¡ÄÚ
  • comet-like echo
    Çý¼º (û²àø) °°Àº ¿¡ÄÚ, Çý¼º (û²àø) °°Àº ¸Þ¾Æ¸®
  • curare-like substances
    Å¥¶ó·¹¾ç¹°Áú(¡­åÆÚªòõ).
  • dream state, dream-like state, dreamy state
    ¸ù·Õ»óÅÂ(ÙÔÖèßÒ÷¾).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • wart like process
    (³¶¹ÌÃæÀÇ) »ç¸¶±Íµ¹±â
  • antiamebic drug
    ¾Æ¸Þ¹Ù±¸ÃæÁ¦
  • antimalarial drug
    Ç׸»¶ó¸®¾ÆÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine
    ¸ð¸£ÇÉ
  • DNA-like RNA
    DNAÀ¯»ç(×¾ÞÄ) RNA
  • giant messenger-like RNA
    °Å´ë(ËÝÓÞ) À¯»çÀü·É(×¾ÞÄîîÖµ) RNA
  • glucagon-like immunoreactivity
    ±Û·çij°ïÀ¯»ç(×¾ÞÄ) ¸é¿ªÈ°¼º(Øóæ¹üÀàõ)
  • suppressible insulin-like activity
    ¾ï¾Ð °¡´É(åääâʦÒö) Àν¶¸°À¯»çȰ¼º(×¾ÞÄüÀàõ)
  • t-like RNA
    tÀÚÇü (í®úþ) RNA
  • troponin C-like protein
    Æ®·ÎÆ÷´Ñ C À¯»ç ´Ü¹éÁú(Ó±ÛÜòõ)
  • drug-detoxication enzyme
    ¾à¹°Çص¶ È¿¼Ò(å·Úªú°Ô¸ý£áÈ) (ÔÒ) drug-metabolizing enzyme
  • drug-metbolizing enzyme
    ¾à¹°´ë»ç È¿¼Ò(å·ÚªÓÛÞóý£áÈ)
  • drug resistance
    ¾à¹° ÀúÇ×(å·Úªî½ù÷)
  • drug-resistance plasmid
    ¾à¹°ÀúÇ×(å·Úªî½ù÷) Çö󽺹̵å (ÔÒ) R plasmid
  • narcotic drug
    ¸¶¾à(ئå·)
  • psychedelic drug
    ȯ°¢Á¦(ü³ÊÆð¥)
  • radiomimetic drug
    ¹æ»ç¼± ¾ç(À¯»ç) ¾à¹°(Û¯ÞÒàÊåÆ(ëºÞÄ)å·Úª)
  • sulfa drug
    ¼³ÆÄÁ¦(ð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morphine
    ¸ð¸£ÇÉ
  • bud like
    ²ÉºÀ¿À¸®°°Àº, »õ½Ï¸ð¾ç
  • comet like echo
    Çý¼º¸ð¾ç¿¡ÄÚ
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • drug abuse
    ¾à¹°³²¿ë
  • finger like projection
    ¼Õ°¡¶ô¸ð¾çÀÇ µ¹Ãâ
  • narcotic drug
    ¸¶¾à
  • plate like atelectasis
    ÆòÆÇ¾ç¹«±âÆó, ÆÇ¾ç¹«±âÆó
  • tuberculostatic drug
    Ç×°áÇÙ¾à
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DA dark adaptation; dark agouti [rat]; daunomycin; degenerative arthritis; delayed action; Dental Assis...
MLC minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen...
MLF medial longitudinal fasciculus; morphine-like factor
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
DAST drug abuse screening test; drug and alcohol screening test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EM Epidural morphine
10(-6) M Morphine
M Morphine
MOR Morphine
Mo Morphine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • morphine like drug
    ¸ð¸£ÇÉ À¯»ç ¾à¹°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • IGF-I : insulin like growth factor-IÀÇ ¾àÀÚ. ¼ºÀåÆÇÀÎ epiphyseal plate¿¡ ¿¬°ñ »ý¼ºÀ» Áõ°¡½ÃÄÑ »ÀÀÇ ¼ºÀåÀ» ÃËÁøÇÑ´Ù.

    IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡

    Àν¶¸°¾ç ¼ºÀå ÀÎÀÚ °áÇÕ ´Ü¹éÁú
    insulinelike growth factor binding
  • morphine acetate
    ÃÊ»ê ¸ð¸£ÇÉ
  • morphine euphoria
    ¸ð¸£ÇÉ ´ÙÇà°¨, ¸ð¸£ÇÉ Äè°¨
  • morphine test
    ¸ð¸£ÇÉ ½ÃÇè
  • like drug
    ¸ð¸£ÇÉ À¯»ç ¾à¹°
  • bubble like cauliflower appearance
    ¹èÃß ²É ¸ð¾ç °°Àº °Åǰ
  • buffalo-like torso : ÄÚÆ¼Á¹ÀÌ °ú´ÙÇÏ°Ô ºÐºñµÉ ¶§ ÆÈ°ú ´Ù¸®ÀÇ Áö¹æ ÃàôÀº °¨¼ÒÇÏ°í ¾î±ú¿Í ¸öÅë ºÎºÐÀÇ Áö¹æ ÃàôÀº Áõ°¡ÇÏ°Ô µÇ´Âµ¥ ÀÌ·± Çö»óÀ¸·Î ÃëÇÏ°Ô µÇ´Â Ư¡ÀûÀÎ ¸ö ÇüŸ¦ ¸»ÇÑ´Ù.

    buffer

    ¿ÏÃæ¾×, ¿ÏÃæÁ¦
    1. ´Ù¸¥ È­Çй°ÁúÀÇ ³óµµ º¯È­¸¦ ¾ïÁ¦ÇÏ´Â È­Çаè. ¿¹ÄÁ´ë ¾çÀÚ °ø¿©Ã¼¿Í ¼ö¿ëü°è´Â ¼ö¼Ò À̿ ³óµµÀÇ ½ÉÇÑ º¯È­¸¦ ¾ïÁ¦ÇÏ´Â ¿ÏÃæ°è·Î ÀÛ¿ëÇÑ´Ù. ÁÖ·Î ¾à»ê, ¾à¿°±â·Î¼­, ¾î´À Á¤µµ ¹±È÷°Å³ª ¼Ò·®ÀÇ »ê ¶Ç´Â ¿°±â¸¦ ³Ö¾îµµ ¿ë¾× ¿ø·¡ÀÇ
  • cauliflower like
    ¾ç¹èÃß ²É °°Àº, ¾ç¹èÃß ²É ¸ð¾ç
    Á¼Àº ±âÀúºÎ¿Í ºñ±³Àû Å« ºñ´ë»óÀÇ ¸ð¾ç. ÆíÆòÇü À¯µÎÁ¾¿¡¼­ º¼ ¼ö ÀÖ´Ù.
  • cobblestone-like appearance
    ºÒ±ÔÄ¢ÀûÀÌ°í ±Ë¾ç¼ºÀÎ ¾ç»ó
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • dust like particle
    ¸ÕÁö °°Àº ÀÔÀÚ
  • dust-like cataract
    ºÐÁø ¹é³»Àå
  • finger like projection
    ¼Õ°¡¶ô ¸ð¾çÀÇ µ¹Ãâ
  • fold like pattern
    Ãߺ® ¾ç»ó
  • hormone like action
    È£¸£¸ó À¯»ç ÀÛ¿ë
    ü³»¿¡ µé¾î¿Í È£¸£¸ó°ú ºñ½ÁÇÑ ¿ªÇÒÀ» ÇÏ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
drug-drug interaction The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity.
(09 Oct 1997)
morphine <drug> An opioid alkaloid, isolated from opium, with a complex ring structure. It is a powerful analgesic with important medical uses, but is highly addictive. Functions by occupying the receptor sites for the natural neurotransmitter peptides, endorphins and enkephalins, but is stable to the peptidases that inactivate these compounds.
Pharmacologic action: Narcotic analgesia, increases venous capacitance and reduces systemic vascular resistance.
Uses: Analgesic for ischemic chest pain, hemodynamic changes lead to reduced pulmonary congestion, reduced myocardial oxygen demand.
Dose: 1-3 mg slow IV increments until desired effect.
Potential complications: Respiratory depression, hypotension, especially in hypovolemic patients.
(17 Mar 2000)
morphine 6-dehydrogenase <enzyme> Catalyses the dehydrogenation of morphine in position 6 to morphinone; also acts on codeine, normorphine and ethylmorphine
Registry number: EC 1.1.1.218
Synonym: naloxone reductase
(26 Jun 1999)
morphine dependence Strong dependence, both physiological and emotional, upon morphine.
(12 Dec 1998)
morphine derivatives Analogs or derivatives of morphine.
(12 Dec 1998)
morphine hydrochloride White acicular or cubical crystals of bitter taste, soluble in about 25 parts of water.
(05 Mar 2000)
morphine injector's septicaemia Blood stream infection in an individual who injects him or herself with narcotics, usually intravenously, due to bacterial contamination of equipment used. Seen more often with heroin and narcotics other than morphine.
(05 Mar 2000)
morphine sulfate Morphine used for formulation of tablets as well as solutions for parenteral, epidural, or intrathecal injection to relieve pain.
(05 Mar 2000)
african swine fever-like viruses An unnamed, unclassified genus of DNA viruses with a single species: african swine fever virus.
(12 Dec 1998)
anterior pituitary-like hormone A glycoprotein with a carbohydrate fraction composed of d-galactose and hexosamine, extracted from the urine of pregnant women and produced by the placental trophoblastic cells; its most important role appears to be stimulation, during the first trimester, of ovarian secretion of the oestrogen and progesterone required for the integrity of conceptus; it appears to play no significant role in the last two trimesters of pregnancy, as the oestrogen and progesterone are then formed by the placenta.
Synonym: anterior pituitary-like hormone, choriogonadotropin, chorionic gonadotropic hormone, chorionic gonadotrophic hormone, placenta gonadotropin, placentagonadotropin.
(05 Mar 2000)
Artemia trypsin-like proteinase <enzyme> Cysteine proteinase involved in lipovitellin degradation
Registry number: EC 3.4.22.-
(26 Jun 1999)
box-like heart <radiology> Ebstein's anomaly, massive cardiomegaly, primarily RA enlargement
(12 Dec 1998)
broom-like <botany> Describes a plant which has many branches parallel or almost so and usually erect.
(09 Oct 1997)
gallus adeno-like virus A virus with characteristics of adenovirus, not known to be associated with natural disease.
Synonym: gallus adeno-like virus.
(05 Mar 2000)
GCK-like kinase <enzyme> Similar to human germinal centre kinase.
Registry number: EC 2.7.1.-
Synonym: glk kinase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • I should like to ~
    ~ÇßÀ¸¸é ÇÑ´Ù(°â¼ÕÇÑ Ç¥Çö)
  • be like to
    ..Çϱ⠽±´Ù
  • fairy-like
    ¿äÁ¤°°Àº
  • like
    À¯»çÇÑ,-¿Í À¯»çÇÑ,ÁÁ¾ÆÇÏ´Ù
  • something like ~
    ´Ù¼Ò ~¸¦ ´àÀº,´ë·«
  • sound like ~
    ~ó·³ µé¸®´Ù,~ó·³ ´À²¸Áö´Ù
  • like
    ...´àÀº;...°°Àº;ºñ½ÁÇÑ;(°ú¿¬) ...´Ù¿î;...ÀÌ µÉ °Í °°Àº;feel ~ doing ...ÇÏ°í ½ÍÀº »ý°¢ÀÌ µé´Ù;~ nothing on earth µå¹®
  • like
    ...¿Í °°ÀÌ;...ó·³
  • like
    ±âÈ£;ÁÁ¾ÆÇÔ;~s and dislikes °¡¸®´Â °Í
  • like
    ºñ½ÁÇÑ °Í(»ç¶÷);ÇÊÀûÇÏ´Â °Í;and the ~ ...°°Àº °Í;or the ~ ...µûÀ§;the ~s of me (³·Ãß¾î) ³ª°°Àº °Í
  • like
    ...ó·³;~ anything or ~ blazes(fun,mad)¸Í·ÄÈ÷;very ~;or ~ enough ¾Æ¸¶
  • like
    ...ÇÏ°í ½Í´Ù°í »ý°¢ÇÏ´Ù
  • like
    ...¿Í ¶È°°ÀÌ;¾Æ¸¶;¸¶Ä¡ ...°°ÀÌ;as ~ as not ¾Æ¸¶
  • like
    ÁÁ¾ÆÇÏ´Ù;¹Ù¶ó´Ù;...ÇÏ°í ½Í´Ù
  • Food and Drug Administration
    ½Äǰ ÀǾ౹(º¸°Ç ±³À° º¹Áö¼ºÀÇ ÀϺÎ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á